Clinical Study

Hearing Assessment after Treatment of Nasopharyngeal Carcinoma with CRT and IMRT Techniques

Table 2

Factors predicting the average air and bone conduction threshold deterioration at the 1- to 5-year follow-up after RT.

Variables (= 182)Air (dB)
Mean ± SEM
valueBone (dB)
Mean ± SEM
value

Sex
 Female5315.67 ± 3.020.5569.05 ± 12.270.591
 Male12917.64 ± 1.6510.12 ± 12.05
Radiation modality
 2D-3D CRT7524.00 ± 2.340.00014.04 ± 1.540.000
 IMRT10712.21 ± 1.716.85 ± 0.99
Age (years)
50 8918.73 ± 2.300.26710.55 ± 1.380.421
509315.47 ± 1.819.10 ± 1.15
Treatment regimen
 RT alone8919.93 ± 2.230.06010.65 ± 1.230.359
 Chemoradiotherapy9314.32 ± 1.869.58 ± 1.30
Radiation dose
72 Gy3510.24 ± 3.010.0176.66 ± 1.650.026
72 Gy14718.69 ± 1.6310.26 ± 1.03
Otitis media effusion
 No11115.54 ± 1.810.0198.09 ± 1.000.016
 Yes7119.46 ± 2.4312.50 ± 1.65

SEM = standard error of the mean; RT = radiotherapy; 2D-3D CRT = 2-dimensional-3-dimensional conformal radiotherapy; IMRT = intensity-modulated radiotherapy.